Autoimmune pancreatitis
Autoimmune pancreatitis
Updated: 02/13/2021
© Jun Wang, MD, PhD
General features
- AKA primary sclerosing cholangitis-like pancreatitis, non-alcoholic duct destructive chronic pancreatitis
- Two subtypes
Lymphoplasmacytic sclerosing autoimmune
pancreatitis
Idiopathic duct centric autoimmune
pancreatitis
- Forms mass that may constrict bile duct
- Clinically and radiological features may mimic malignant tumors
- May cause exocrine and endocrine deficiencies
- Risk factor for pancreatic cancer
- Overall excellent prognosis
Lymphoplasmacytic sclerosing autoimmune pancreatitis
- IgG4 related systemic disease
- More common in male, older patients, often presents with jaundice
- Associated with sclerosing cholangitis, IgG4 related dacryoadenitis and sialadenitis, Sjögren-like syndrome, retroperitoneal fibrosis, obliterative phlebitis, arterial involvement
Idiopathic duct centric autoimmune pancreatitis
- No gender preference, younger patients, associated with inflammatory bowel diseases, not with obliterative phlebitis
- No known causes for usual chronic pancreatitis, nor features of classic chronic pancreatitis (fat necrosis, pseudocyst, calcification, etc.)
- Compared to chronic pancreatitis NOS, more foci of periductal inflammation and neutrophilic microabscesses
Key pathological features
- Lymphoplasmacytic sclerosing autoimmune pancreatitis
Hypercellular lymphoplasmacytic infiltrate
of interlobular stroma
Storiform type fibrosis
>10 IgG4+
plasma cells/high-power field
- Idiopathic duct centric autoimmune pancreatitis
Confined to pancreas (i.e. not systemic)
Microabscesses and ductal ulceration, granulocyte
epithelial lesions
Occasional IgG4 plasma cells (<10/HPF)
Treatment
- Steroid
Back to exocrine pancreas pathology
Back to contents
Comments
Post a Comment